135 related articles for article (PubMed ID: 20694939)
1. [Recovery and remission in schizophrenia. Results from a naturalistic 2-year follow-up inpatient study].
Wolter A; Preuss U; Krischke N; Wong JW; Langosch JM; Zimmermann J
Fortschr Neurol Psychiatr; 2010 Aug; 78(8):468-74. PubMed ID: 20694939
[TBL] [Abstract][Full Text] [Related]
2. Remission in schizophrenia: a community-based 6-year follow-up study in Bali.
Kurihara T; Kato M; Reverger R; Tirta IG
Psychiatry Clin Neurosci; 2011 Aug; 65(5):476-82. PubMed ID: 21851456
[TBL] [Abstract][Full Text] [Related]
3. Improvement of subjective well-being and enduring symptomatic remission, a 5-year follow-up of first episode schizophrenia.
de Haan L; Nimwegen Lv; Amelsvoort Tv; Dingemans P; Linszen D
Pharmacopsychiatry; 2008 Jul; 41(4):125-8. PubMed ID: 18651339
[TBL] [Abstract][Full Text] [Related]
4. Sustaining full recovery in schizophrenia after 15 years: does resilience matter?
Torgalsbøen AK
Clin Schizophr Relat Psychoses; 2012 Jan; 5(4):193-200. PubMed ID: 22182456
[TBL] [Abstract][Full Text] [Related]
5. The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission.
Henry LP; Amminger GP; Harris MG; Yuen HP; Harrigan SM; Prosser AL; Schwartz OS; Farrelly SE; Herrman H; Jackson HJ; McGorry PD
J Clin Psychiatry; 2010 Jun; 71(6):716-28. PubMed ID: 20573330
[TBL] [Abstract][Full Text] [Related]
6. Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?
Schennach-Wolff R; Jäger M; Obermeier M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Kühn KU; Lemke MR; Rüther E; Klingberg S; Gastpar M; Seemüller F; Möller HJ; Riedel M
World J Biol Psychiatry; 2010 Aug; 11(5):729-38. PubMed ID: 20380620
[TBL] [Abstract][Full Text] [Related]
7. Prediction of symptom remission in schizophrenia during inpatient treatment.
Jäger M; Riedel M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Kühn KU; Lemke MR; Rüther E; Buchkremer G; Gastpar M; Bottlender R; Strauss A; Möller HJ
World J Biol Psychiatry; 2009; 10(4 Pt 2):426-34. PubMed ID: 17853260
[TBL] [Abstract][Full Text] [Related]
8. The concepts of remission and recovery in schizophrenia.
Leucht S; Lasser R
Pharmacopsychiatry; 2006 Sep; 39(5):161-70. PubMed ID: 16944406
[TBL] [Abstract][Full Text] [Related]
9. Remission after first-episode schizophrenia: results of a long-term follow-up.
Üçok A; Serbest S; Kandemir PE
Psychiatry Res; 2011 Aug; 189(1):33-7. PubMed ID: 21196051
[TBL] [Abstract][Full Text] [Related]
10. Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study.
Harrow M; Jobe TH
J Nerv Ment Dis; 2007 May; 195(5):406-14. PubMed ID: 17502806
[TBL] [Abstract][Full Text] [Related]
11. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
Wehmeier PM; Kluge M; Schneider E; Schacht A; Wagner T; Schreiber W
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):703-12. PubMed ID: 17289237
[TBL] [Abstract][Full Text] [Related]
12. Cost analysis of treating schizophrenia with amisulpride: naturalistic mirror image study.
Surguladze S; Patel A; Kerwin RW; Knapp M; Travis MJ
Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):517-22. PubMed ID: 15866352
[TBL] [Abstract][Full Text] [Related]
13. Interictal psychoses in comparison with schizophrenia--a prospective study.
Tadokoro Y; Oshima T; Kanemoto K
Epilepsia; 2007 Dec; 48(12):2345-51. PubMed ID: 17666070
[TBL] [Abstract][Full Text] [Related]
14. The impact of intellectual functioning on symptoms and service use in schizophrenia.
Chaplin R; Barley M; Cooper SJ; Kusel Y; McKendrick J; Stephenson D; Obuaya T; Stockton-Henderson J; O'Brien LS; Burns T
J Intellect Disabil Res; 2006 Apr; 50(Pt 4):288-94. PubMed ID: 16507033
[TBL] [Abstract][Full Text] [Related]
15. Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics.
Wunderink L; Nienhuis FJ; Sytema S; Wiersma D
Schizophr Bull; 2007 May; 33(3):792-6. PubMed ID: 16894026
[TBL] [Abstract][Full Text] [Related]
16. Adherence to medication and quality of life in people with schizophrenia: results of a European multicenter study.
Puschner B; Born A; Giessler A; Helm H; Leese M; Bindman JP; Gray RJ; Schene A; Kikkert M; Burti L; Marrella G; Becker T
J Nerv Ment Dis; 2006 Oct; 194(10):746-52. PubMed ID: 17041286
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness of ziprasidone in treating impaired quality of life in schizophrenia: a 12-month, open-label, flexible-dose, naturalistic observational study of patients undergoing usual care.
Ritsner MS; Yorkov V; Ratner Y; Soifer P; Gibel A
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1470-7. PubMed ID: 17669573
[TBL] [Abstract][Full Text] [Related]
18. Reducing the dose of depot neuroleptics in stable schizophrenia.
Dale R; Longdon M; Seeman MV
J Psychiatry Neurosci; 1994 Jul; 19(4):278-81. PubMed ID: 7918349
[TBL] [Abstract][Full Text] [Related]
19. Sociodemographic and clinical factors associated with relapse in schizophrenia.
Chabungbam G; Avasthi A; Sharan P
Psychiatry Clin Neurosci; 2007 Dec; 61(6):587-93. PubMed ID: 18081617
[TBL] [Abstract][Full Text] [Related]
20. Recovery style predicts remission at one-year follow-up in outpatients with schizophrenia spectrum disorders.
Staring AB; van der Gaag M; Mulder CL
J Nerv Ment Dis; 2011 May; 199(5):295-300. PubMed ID: 21543947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
